Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis

Ovarian cancer is the most lethal of all gynaecological cancers among women. Serum CA125 is the only biomarker that is used routinely and there is a need for further complementary biomarkers both in terms of sensitivity and specificity. N-glycosylation changes in ovarian cancer serum glycoproteins i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saldova, Radka, Wormald, Mark R., Dwek, Raymond A., Rudd, Pauline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2008
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827796/
https://www.ncbi.nlm.nih.gov/pubmed/19126966
http://dx.doi.org/10.1155/2008/601583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827796/
https://www.ncbi.nlm.nih.gov/pubmed/19126966
http://dx.doi.org/10.1155/2008/601583

Ejemplares similares